This Enforcement Notice provides guidance to advertiser’s using their social media presence to advertise botulinum toxin products – which are prescription-only medicines (POMs) – to the public. Advertisers may neither directly promote a POM to consumers, nor indirectly promote a POM by implying one that may be offered.
Related guidance and information
Beauty and Cosmetics: Botulinum toxin products
Guidance on the marketing of surgical and non-surgical cosmetic procedures